1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LSO-OL005, NCT00355355
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LSO-OL006, NCT00440310
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LSC-OL004, NCT00122876
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LSC-OL002, AGH-RC-3523, NCT00068068
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: LSC-OL003, NCT00083785
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 19 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LSO-OL007, NCT00409214
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LSC-OL001, LSC-WIRB-20020214, VMRC-8811, NCI-V02-1711
|